DELAPHARMA
Board
1 director, no change since 2024Director (not named in the articles)
since 23-02-2009
term without a fixed end
earlier statutory manager, until 15-01-2024
listed in the 2025 annual accounts, filed on 01-04-2026
Mandates through the years
2 names, the dashed line is todayVictor Delplancke
Director (not named in the articles)
Director (not named in the articles)
PRIEM Annelies
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
- Victor Delplancke
- Director (not named in the articles), from 23-02-2009 to date
- Statutory manager, until 15-01-2024
- PRIEM Annelies
- Director (not named in the articles), appointed by deed of 15-01-2024, no longer listed in the 2025 annual accounts
Control
Capital
- Contribution
- €18,600
- Source
- 2025 annual accounts
Articles of association
deed of 15-01-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Saturday of March